NXPL.US Nextplat Corp

Technology Software USA Stocks
7.02 USD
Close of Nov 15, 2026
3.38 9.94
Market cap
USD 19.0M
P/E
-
P/B
1.22x
ROE
-17.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NXPL.US undervalued?

Graham number

The Graham number of Nextplat Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nextplat Corp fundamental analysis

No fundamental analysis for Nextplat Corp yet.

Nextplat Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nextplat Corp

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication the…

Full company profile